{"id":"W2901760736","doi":"10.1016/s1470-2045(18)30576-x","title":"Targeting B-cell maturation antigen with GSK2857916 antibody–drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial","year":2018,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":244,"is_retracted":false,"has_abstract":false,"ca_institutions":"Vancouver General Hospital; Princess Margaret Cancer Centre","funders":"UCLH Biomedical Research Centre; National Cancer Institute; Cancer Research UK; National Institutes of Health; National Institute for Health and Care Research; GlaxoSmithKline; American Society of Hematology","keywords":"Conjugate; Antibody-drug conjugate; Multiple myeloma; Medicine; Refractory (planetary science); Antibody; Cancer research; Drug; Oncology; Antigen; Internal medicine; Pharmacology; Immunology; Monoclonal antibody; Materials science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008918267,0.0001936688,0.0005353737,0.0001347426,0.0001945973,0.00002709962,0.0001009442,0.000137104,0.0001120005],"category_scores_gemma":[0.0003816281,0.0001060913,0.00003229302,0.0002351619,0.0002674855,0.0001292953,0.00005767826,0.0003511659,0.00004082052],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001583556,"about_ca_system_score_gemma":0.0002701937,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002191285,"about_ca_topic_score_gemma":0.0004146835,"domain_scores_codex":[0.9980774,0.0004802066,0.0003609711,0.0003609073,0.0002654383,0.0004550954],"domain_scores_gemma":[0.9987016,0.0005136667,0.0002062823,0.0003159383,0.0001294744,0.000133025],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.682031,0.00199697,0.03416089,0.0001409081,0.0001157652,0.0006250221,0.002625313,0.000006773062,0.2483207,0.00001545899,0.00123887,0.02872235],"study_design_scores_gemma":[0.7461123,0.02597614,0.151774,0.0003593582,0.0001605784,0.0002153075,0.00109156,0.02904672,0.02511526,0.00008702136,0.01961272,0.0004490257],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953901,0.000198436,0.0001176314,0.00156644,0.0001694135,0.001715879,0.00001899045,0.00006168916,0.0007614418],"genre_scores_gemma":[0.9958239,0.0004290467,0.00197514,0.0002910034,0.0008820641,0.00007897225,0.0001894547,0.00002759169,0.0003028283],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2232054,"threshold_uncertainty_score":0.4326277,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0496385688750652,"score_gpt":0.384529794605185,"score_spread":0.3348912257301199,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}